Evidence map›Paper›PMID 34969968›Full record

ArticleScientific reports2021

Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule.

George A Syrogiannopoulos, Ioanna N Grivea, Maria Moriondo, Francesco Nieddu, Aspasia N Michoula, Maria Rita Calabrese, Michael Anthracopoulos, Chiara Azzari

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Nasopharyngeal carriage ofFrontiers in pediatrics · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

George A SyrogiannopoulosDepartment of Pediatrics, University of Thessaly, School of Health Sciences, Faculty of Medicine, Biopolis, Larissa, Greece. syrogian@otenet.gr.
Ioanna N GriveaDepartment of Pediatrics, University of Thessaly, School of Health Sciences, Faculty of Medicine, Biopolis, Larissa, Greece.
Maria MoriondoUniversity of Florence and Anna Meyer Children's Hospital, Florence, Italy.
Francesco NiedduUniversity of Florence and Anna Meyer Children's Hospital, Florence, Italy.
Aspasia N MichoulaDepartment of Pediatrics, University of Thessaly, School of Health Sciences, Faculty of Medicine, Biopolis, Larissa, Greece.
Maria Rita CalabreseUniversity of Florence and Anna Meyer Children's Hospital, Florence, Italy.
Michael AnthracopoulosDepartment of Pediatrics, University of Patras, Patras, Greece.
Chiara AzzariUniversity of Florence and Anna Meyer Children's Hospital, Florence, Italy.
University of Thessaly · GRMeyer Children's Hospital · ITUniversity of Florence · ITUniversity of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a cross-sectional study, with the use of molecular methods, we aimed to gain insight into oropharyngeal pneumococcal colonization over time in 1212 Greek children recruited in general pediatric settings throughout the country; they were fully vaccinated with PCV13 (3 + 1 schedule). A single sample was obtained from each child at a time interval of 26 days to 70 months after administration of the 4th (booster) PCV13 dose; sampling time was divided into six time intervals. Carriage of Streptococcus pneumoniae was detected by real-time PCR targeting the lytA gene and isolates were serotyped by singleplex real-time PCR assays. Multiple control procedures to avoid false-positive results were applied. We showed an overall S. pneumoniae carriage rate of 48.6%. Serotyping identified typeable isolates in 82% of the total lytA-positive samples. Non-PCV13 serotypes represented 83.8% of total isolates when excluding serogroups with mixed PCV13 and non-PCV13 serotypes. In multivariate analysis daycare/school attendance emerged as the main contributing factor. Notably, serotypes 19A and 3 were the only two PCV13 serotypes the colonization rate of which increased over time (χ

Indexed as

ChildChild, PreschoolCross-Sectional StudiesFemaleHumansImmunizationInfantMalePneumococcal InfectionsPneumococcal VaccinesStreptococcus pneumoniaeVaccines, Conjugate13-valent pneumococcal vaccinePneumococcal VaccinesVaccines, Conjugate

Identifiers

PMID34969968
PMCPMC8718523
OpenAlexW4200207579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.